COVERAGE
March 24, 2022
Read time: 2 min
Partners, Jerry Sokol and Dana Dombey are named in Daily Business Review‘s Florida Legal Awards honorees.
COVERAGE
March 23, 2022
Read time: 2 min
Partner, Ted Diskant is quoted in this Law360 article.
“From the government’s perspective, a strong urging from the bench that jurors should not talk about deliberations is welcome,” said Edward Diskant of McDermott Will & Emery LLP, who prosecuted basketball corruption cases in front of Judge Kaplan before moving to private practice. “To the extent they can so instruct jurors, consistent with the law, I would imagine that judges generally share the government’s perspective — very little good can come from jurors talking with the media.”
COVERAGE
March 22, 2022
Read time: 2 min
McDermott is featured in this Global Legal Chronicle article for representing Ampersand Capital Partners in its business combination of Biosynth Carbosynth and Vivitide, Inc.
The cross-border US, UK, Germany and Belgium team was led by Kristian Werling, Lindsey Reighard and Calum Thom with corporate support from John Prinzivalli, Simon Margesson, Christian Marzlin, Michael Cziesla, Deniz Tschammler, Lea Hachmeister, Lisa Schickling, Jana Grieb, Gudrun Germakowski and Lukas Deutzmann. Hendrik Viaene led the global regulatory approval process with support from Carina Kant and Anja Bertrand. Global tax structuring was led by Michael Bruno with support from Alejandro Ruiz and the finance team was led by Anh Lee with support from Libby Jacobson.
COVERAGE
March 18, 2022
Read time: 2 min
Partners, Ted Becker and J. Christian Nemeth are featured in this Law360 article.
DEAL ANNOUNCEMENT / PRESS RELEASE
March 18, 2022
Read time: 4 min
International law firm McDermott Will & Emery represented Ampersand Capital Partners, a healthcare-focused private equity fund, in its investment with KKR, a leading global investment firm, in the business combination of Biosynth Carbosynth, an innovative life sciences reagents, custom synthesis and manufacturing services company, and Vivitide Inc., a global leader in custom peptides and antibody services. Together, KKR and Ampersand plan to accelerate the company’s geographic expansion, broaden its capabilities and expand its product portfolio.
McDermott’s private equity practice is among the top four most active PE law firms globally and in the US with more than 160 dedicated private equity lawyers in 21 locations globally. In addition to being Pitchbook’s top Healthcare PE firm for a fourth consecutive year and fifth in both IT and financial services private equity, we are named Energy & Industrials Law Firm of the Year (Large Cap) by The Deal, Top 10 in PE Buyouts by MergerMarket and Top 10 in US Mid-Market by Bloomberg. Learn more about our PE practice by visiting pe.mwe.com.
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices, industries and more than 20 locations to deliver highly effective—and often unexpected—solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.
COVERAGE
March 11, 2022
Read time: 2 min
The new year holds some important legislative changes for the real estate industry that require your attention. In this article, Hannah Henseling, Maximilian Clostermeyer and Johannes Honzen would like to provide you with the most important information at a glance on some selected legislative changes that have already come into force and are likely to come into force in the future. To this end, they also take a look at the coalition agreement for you.
COVERAGE
March 17, 2022
Read time: 2 min
Ethan Townsend, William Gaede, Sarah Chapin Columbia, Sarah Fischer and Ian Brooks are featured in Law360.
DEAL ANNOUNCEMENT / PRESS RELEASE
March 17, 2022
Read time: 3 min
Munich, March 17, 2022 – McDermott Will & Emery advised Danish customer service innovator Dixa ApS on its acquisition of Solvemate GmbH.
The Copenhagen-based software-as-a-service company Dixa ApS was founded in 2015 and now has additional offices in London, Berlin, Paris, Chicago, Tallinn, Kiev, Tel Aviv, and Melbourne. Dixa has raised USD 155 million in growth capital to date from General Atlantic, Notion Capital, Project A Ventures and SEED Capital.
Founded in 2015, Berlin-based Solvemate GmbH operates a platform for automated and personalized customer service using AI-powered chatbot conversations in real time. Its customer base includes more than 100 brands, including e.g. On, JustPark, Sport24, Holidu and CreditPlus.
The McDermott team advising Dixa ApS was led by Tobias Koppmann and included Christian Rolf (Arbeitsrecht, Frankfurt), Marcus Fischer (Counsel), Nina Siewert (beide Steuerrecht, beide Frankfurt), Claus Färber (Counsel, Datenschutzrecht); Associates: Benjamin Maciejewski, Sebastian Gerstner (beide Corporate/M&A), Ilva Woeste (Arbeitsrecht)
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices, industries and more than 20 locations to deliver highly effective—and often unexpected—solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.
COVERAGE
March 16, 2022
Read time: 3 min
The UK Government, through the Medicines and Healthcare Products Regulatory Agency (MHRA) (the medicines and medical device regulator in the United Kingdom), recently announced a consultation to change the UK clinical trial regulations.
Following the United Kingdom’s departure from the European Union, the UK Government is seeking to create an attractive regulatory environment for clinical trials alongside a programme that is intended to enhance the United Kingdom’s status as a go-to destination for the development of new healthcare products and innovation. The Government set out its wider life sciences ambitions in July 2021 in its Life Sciences Vision.
McDermott’s Health lawyers Sharon Lamb and David Gibson explain the details of the consultation in an article in Health Tech World.
AWARDS & RANKINGS / COVERAGE
March 16, 2022
Read time: 2 min
Marshall Jackson was given the Rising Star Award by the University of Maryland Francis King Carey School of Law.
